5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.62%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
6.88%
Gross profit growth at 50-75% of HUH1V.HE's 9.47%. Martin Whitman would question if cost structure or brand is lagging.
12.52%
EBIT growth below 50% of HUH1V.HE's 31.59%. Michael Burry would suspect deeper competitive or cost structure issues.
12.52%
Operating income growth under 50% of HUH1V.HE's 31.59%. Michael Burry would be concerned about deeper cost or sales issues.
-9.83%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-9.52%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-9.52%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.08%
Share count expansion well above HUH1V.HE's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.08%
Diluted share count expanding well above HUH1V.HE's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
80.06%
Positive OCF growth while HUH1V.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
798.98%
Positive FCF growth while HUH1V.HE is negative. John Neff would see a strong competitive edge in net cash generation.
14.23%
10Y revenue/share CAGR under 50% of HUH1V.HE's 81.21%. Michael Burry would suspect a lasting competitive disadvantage.
11.52%
5Y revenue/share CAGR under 50% of HUH1V.HE's 44.04%. Michael Burry would suspect a significant competitive gap or product weakness.
19.20%
3Y revenue/share CAGR at 75-90% of HUH1V.HE's 23.95%. Bill Ackman would expect new product strategies to close the gap.
222.39%
10Y OCF/share CAGR under 50% of HUH1V.HE's 1960.01%. Michael Burry would worry about a persistent underperformance in cash creation.
323.88%
5Y OCF/share CAGR at 50-75% of HUH1V.HE's 634.04%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
64.02%
3Y OCF/share CAGR under 50% of HUH1V.HE's 656.09%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
856.85%
Net income/share CAGR above 1.5x HUH1V.HE's 99.55% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
27.58%
5Y net income/share CAGR 1.25-1.5x HUH1V.HE's 18.99%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
218.95%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
162.49%
10Y equity/share CAGR 1.25-1.5x HUH1V.HE's 121.60%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
72.58%
5Y equity/share CAGR 1.25-1.5x HUH1V.HE's 57.38%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
53.08%
3Y equity/share CAGR 1.25-1.5x HUH1V.HE's 35.88%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Cut dividends over 10 years while HUH1V.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.30%
Firm’s AR is declining while HUH1V.HE shows 4.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.14%
Inventory growth well above HUH1V.HE's 2.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.87%
Positive asset growth while HUH1V.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-6.05%
We have a declining book value while HUH1V.HE shows 0.24%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.29%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 14.47%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.92%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.